Why the study?
Does aortic valve replacement improve survival compared to medical therapy alone in patients with bacterial endocarditis and aortic insufficiency?
Does aortic valve replacement improve survival compared to medical therapy alone in patients with bacterial endocarditis and aortic insufficiency?
Early aortic valve replacement is indicated in patients with bacterial endocarditis and aortic insufficiency complicated by heart failure to prevent sudden death and improve survival.
AVR associated with survival benefit in severe HF; leaves open need for RCTs in endocarditis with AI.
The records of 28 patients with bacterial endocarditis and aortic valve insufficiency were studied to determine clinical indications for valve replacement before bacteriologic cure can be accomplished. The four patients who never developed heart failure did well with medical therapy alone. Seven of 11 patients with mild heart failure died suddenly during treatment. At autopsy four of these were found to have had myocardial infarctions, presumably embolic. Seven of eight patients with moderate or severe heart failure who were treated medically died, whereas four of five with severe heart failure who had aortic valve replacement survived. Patients with bacterial endocarditis and aortic insufficiency who have severe heart failure should have aortic valve replacement performed immediately. Early valve replacement should also be considered in patients with only mild heart failure because they appear to be at significant risk of sudden death from embolic myocardial infarction or arrhythmia.
No takes yet. Share an insight, caveat, or question.
Frank Griffin (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: